|
Changes in medication among patients taking insulin at baseline |
||
| Participant |
Week 0: Total daily dose |
Week 24: Total daily dose |
|
|
||
| Low-glycemic, reduced-calorie diet group (total n = 29) |
||
| 1 |
insulin 24 units |
none |
| insulin sliding scale three times a day |
none |
|
| 2 |
insulin 85 units |
insulin 13 units |
| 3 |
insulin 160 units |
insulin 120 units |
| Low-carbohydrate, ketogenic diet group (total n = 21) |
||
| 1 |
insulin 50 units |
none |
| 2 |
insulin 90 units |
none |
| 3 |
insulin 32 units |
none |
| rosiglitizone 4 mg/metformin 2000 mg |
metformin 1000 mg |
|
| 4 |
insulin 40 units |
none |
| metformin 2000 mg |
metformin 2000 mg |
|
| 5 |
insulin 40 units |
insulin 35 units |
| insulin sliding scale three times a day |
none |
|
| 6 |
insulin 120 units |
insulin 90 units |
| metformin 2000 mg |
metformin 2000 mg |
|
| 7 |
insulin 135 units |
insulin 60 units |
| 8 |
insulin 80 units |
insulin 8 units |
| pioglitazone 45 mg |
pioglitazone 45 mg |
|
| glimiperide 8 mg |
glimiperide 8 mg |
|
|
*Medications were adjusted using a pre-specified algorithm based upon home and return visit blood capillary glucose measurements. | ||
Westman et al. Nutrition & Metabolism 2008 5:36 doi:10.1186/1743-7075-5-36 |
||